Edition:
United States

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

148.28USD
22 Aug 2017
Change (% chg)

$2.14 (+1.46%)
Prev Close
$146.14
Open
$146.44
Day's High
$149.02
Day's Low
$145.79
Volume
382,185
Avg. Vol
395,680
52-wk High
$194.62
52-wk Low
$114.54

Latest Key Developments (Source: Significant Developments)

Allscripts to acquire Mckesson’s Enterprise Information Solutions business
Thursday, 3 Aug 2017 04:01pm EDT 

Aug 3 (Reuters) - Allscripts Healthcare Solutions Inc :Allscripts to acquire Mckesson’s enterprise information solutions business.Allscripts to acquire Mckesson’s Enterprise Information Solutions business.Allscripts Healthcare Solutions Inc - deal for ‍$185 million​.Allscripts Healthcare Solutions Inc - ‍Allscripts intends to fund purchase price through its existing secured credit facilities and cash balances​.Allscripts Healthcare Solutions Inc - ‍definitive agreement to acquire Mckesson Corporation's hospital and health system IT business​.  Full Article

McKesson says continues to see competitive market for selling generic pharmaceuticals in the U.S.
Thursday, 27 Jul 2017 09:41am EDT 

July 27 (Reuters) - Mckesson :Says entered year with assumption of branded inflation in mid-single digits, and q1 experience was slightly ahead of the assumption - conf call.Says continue to see competitive market for selling generic pharmaceuticals in the u.s., but with less pricing variability- conf call.Says expect to lap the independent pharmacy sell-side pricing impact by the end of our fiscal 2018 second quarter - conf call.Says comfortable with fiscal '18 assumption; reiterates results will be more heavily weighted to second half of fiscal year - conf call.Says "seeing a litlte bit less of a frequency" with regards to branded manufacturer pricing environment - conf call.  Full Article

Mckesson reports fiscal 2018 first-quarter results
Thursday, 27 Jul 2017 07:30am EDT 

July 27 (Reuters) - Mckesson Corp :Mckesson reports fiscal 2018 first-quarter results.Sees FY2018 adjusted earnings per share $11.80 to $12.50.Q1 adjusted earnings per share $2.46.Q1 GAAP earnings per share $1.44 from continuing operations.Q1 revenue $51.1 billion versus I/B/E/S view $51.23 billion.Q1 earnings per share view $2.83 -- Thomson Reuters I/B/E/S.Sees FY2018 GAAP earnings per share $7.10 to $9.00 from continuing operations.Says board of directors approved raising quarterly dividend by 21 pct from 28 cents to 34 cents per share..FY2018 earnings per share view $12.11 -- Thomson Reuters I/B/E/S.Says Q1 results included lapping effect of lower profit contribution from increased price competition in co's independent pharmacy business in 2017.Says Q1 results also included weaker pharmaceutical manufacturer pricing trends in U.S. Pharmaceutical business within distribution solutions segment.  Full Article

Three U.S. state treasurers ask McKesson to help address opioid epidemic
Tuesday, 25 Jul 2017 12:13pm EDT 

July 25 (Reuters) - State Treasurers of Illinois, Pennsylvania and West Virginia::State Treasurers of Illinois, Pennsylvania and West Virginia send letter to McKesson Corp to help address heroin and opioid epidemic.State Treasurers of Illinois, Pennsylvania, West Virginia ask McKesson to change company bylaws to provide for an independent board chair - letter.Treasurers of Illinois, Pennsylvania, West Virginia ask McKesson to connect executive compensation with progress in combating opioid epidemic - letter.Should McKesson not act upon request, treasurers will re-evaluate state’s investment position in company.  Full Article

McKesson reaffirms fiscal 2018 guidance
Wednesday, 28 Jun 2017 08:30am EDT 

June 28 (Reuters) - McKesson Corp :McKesson reaffirms fiscal 2018 guidance.FY2018 earnings per share view $12.14, revenue view $205.28 billion -- Thomson Reuters I/B/E/S.  Full Article

Mckesson CEO John Hammergren's FY2017 total compensation was $20.1 mln
Friday, 16 Jun 2017 08:33am EDT 

June 16 (Reuters) - Mckesson Corp :CEO John Hammergren's FY 2017 total compensation was $20.1 million versus $23.6 million in fy 2016 - SEC filing.CFO James Beer total compensation in 2017 was $5.1 million versus $6.1 million in 2016.Executive vice president and group president, Paul Julian total compensation in 2017 was $13.1 million versus $15.1 million in 2016.  Full Article

Uniprix shareholders approve at 95% Mckesson Canada's bid to acquire Uniprix
Tuesday, 16 May 2017 05:18pm EDT 

May 16 (Reuters) - Mckesson Corp :At shareholder meeting, shareholders approved 95% to Mckesson Canada's bid to acquire all outstanding shares of Uniprix.  Full Article

Mckesson Canada announces plan to acquire Uniprix
Wednesday, 12 Apr 2017 01:15pm EDT 

Mckesson Canada : Mckesson Canada announces plan to acquire Uniprix, strengthening the future of independent pharmacy in quebec .Mckesson Canada - as part of acquisition, individual pharmacies will remain independently owned.  Full Article

Mckesson anticipates recording pre-tax gain of about $2.9 to $3.5 bln in Q4
Thursday, 2 Mar 2017 11:05am EST 

Mckesson Corp : As a result of net gain from transaction, co to add about $10.70-$12.35 in Q4 GAAP earnings per share from continuing operations . Mckesson provides financial update to reflect creation of a new healthcare information technology company . Sees FY 2017 earnings per share $20.35 to $22.50 from continuing operations . Q4 earnings per share view $3.15 -- Thomson Reuters I/B/E/S . Previous fiscal 2017 guidance range updated to reflect timing effect related to closing of transaction . In conjunction with creation of new company, change healthcare raised approximately $6.1 billion in debt . In its Q4 results, Mckesson anticipates recording a pre-tax gain of approximately $2.9 billion to $3.5 billion . Mckesson owns approximately 70 pct of change healthcare, with remaining equity ownership held by CHC stockholders . Sees 2017 earnings per share of $12.45 to $12.75/diluted share, which excludes about $1.28 to $1.30 in charges to adjusted earnings related to goodwill impairment . Mckesson's 70 pct share of change healthcare's initial annual interest expense run rate is expected to be approximately $200 million . Mckesson will account for its equity share of change healthcare's earnings on a one-month lag . Mckesson says non-cash adjustment from transaction close process to reduce co's reported earnings in fiscal 2018 by approximately $140 million to $170 million.  Full Article

Mckesson announces purchase of CoverMyMeds
Thursday, 26 Jan 2017 07:00am EST 

McKesson Corp : McKesson announces purchase of CoverMyMeds, a Francisco Partners portfolio company . McKesson Corp - deal for to $1.4 billion .Once transaction closes, CoverMyMeds CEO Matt Scantland will continue to lead CoverMyMeds with existing leadership team.  Full Article

BRIEF-James Beer, EVP, CFO of Mckesson Corporation, joins Alaska Air board of directors

* James Beer, EVP, CFO of Mckesson Corporation, joins Alaska Air Group board of directors